Find clinical trials for crohn's disease. Search for crohn's disease clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 129
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Los Angeles CA, Murrieta CA, Orange CA, Clearwater FL,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Active & Responsive
Low Dose IL-2 for the Treatment of Crohn's Disease
for
Crohn Disease
Location: Boston MA, New York NY
Sponsor: Boston Children's Hospital
Sex: All
Age: 12 - 70+
Code: NCT04263831
Phase1, Phase2, Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Get alerts for new trials in your area by subscribing now
By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
for
Crohn's Disease
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 65
Code: NCT03167437
Phase1, Phase2, Recruiting
Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease
for
Inflammatory Bowel Diseases, Crohn's Disease,
Location: Hamilton
Sponsor: McMaster University
Sex: All
Age: 18 - 70
Code: NCT06548399
Recruiting
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for
Crohn's Disease
Location: Quebec, Dothan AL, Mobile AL, Coronado CA, La Jolla CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06548542
Phase2, Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
for
Ulcerative Colitis, Ulcerative Colitis Chronic,
Location: San Francisco CA, Hartford CT, Atlanta GA, Boston MA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 2 - 19
Code: NCT04844606
Phase3, Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
for
Moderately to Severely Active Crohn's Disease, Crohn Disease,